Quantcast Section III. Analeptic Agents (Brain Stem Stimulants) - Pharmacology I

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(3)  Methamphetamine hydrochloride (Desoxyn). This drug is similar to
dextroamphetamine in terms of its ability to suppress the appetite. However, its abuse
potential is such that it is rarely used any longer for this purpose.
c.  Other Agents. Many other drugs produce pharmacological effects similar
to those produced by the amphetamines. These are most often used for their ability to
suppress the patient's appetite. Sometimes you will find these medications combined
with other drugs (for example, a sedative or an antianxiety agent) in order to counteract
the stimulation they produce.
(1)  Pemoline (Cylert). This drug is used in the treatment of ADHD. It is
usually prescribed in a graduated dose - beginning with a 37.5-milligram daily dose. It
is then gradually increased at 1-week intervals of 18.75 milligrams until a desired clinical
response is observed. The most common side effect seen with this agent is insomnia.
Pemoline appears to have a lower abuse potential than methylphenidate; pemoline is
classified as a Note Q drug. The drug is supplied in the form of 18.75, 37.5, and 75
milligram tablets.
(2)  Diethylpropion hydrochloride (Tenuate). Diethylpropion hydrochloride
is used as an appetite suppressant. It is less effective in this use than the
amphetamines. It produces such side effects as dryness of the mouth, nausea, and
headaches. It is available in both 25-milligram tablets and 75-milligram (timed-release)
tablets. Diethylpropion is a Note Q drug.
(3)  Phendimetrazine tartrate (Prelu-2). This drug is used as an appetite
suppressant. Long-term use of the drug, especially in large doses, may produce
psychic dependence. It produces such side effects as nervousness, excitement,
euphoria, and dryness of the mouth. It is supplied in 35-mIlligram tablets and capsules
and 105-milligram (timed-release) capsules. Phendimetrazine is a Note Q drug.
Section III. ANALEPTIC AGENTS (BRAIN STEM STIMULANTS)
10-6. INTRODUCTION
a.  Analeptic agents are drugs that produce two primary effects. One, they
stimulate the nerve cells of the body's respiratory center when it has been depressed by
some condition (for example, illness or drugs). Two, they stimulate nerve cell centers
responsible for keeping a person conscious.
b.  Analeptic agents are not commonly used today because of the stimulation
they produce in doses sufficient to produce their analeptic effect. These agents can
produce such undesirable effects as convulsions, respiratory problems, or vomiting.
MD0804
10-5



Medical News
Ebola-hit Liberia delays school reopening
Liberia's education ministry said on Sunday it had postponed by...
medicalxpress.com
Culturally sensitive palliative care represents new approach
When doctors diagnosed Pilar Alcantara with advanced breast cancer, she...
medicalxpress.com
PCMHs Improve Utilization, Cut Costs: Report
(MedPage Today) -- Researchers looked at 28 studies of patient-centered...
medpagetoday.com
Neural Circuit May Control Binge Eating (CME/CE)
(MedPage Today) -- Researchers ID brain pathway linked to compulsive...
medpagetoday.com
How Doctors Can Win the Vaccine Debate With Patients
(MedPage Today) -- Fears and misinformation can be overcome, expert...
medpagetoday.com
The HAC No One Wants to Talk About
(MedPage Today) -- Program to prevent delirium in ICU patients...
medpagetoday.com
Dr. Maiden Name Will See You Now
(MedPage Today) -- Medical students give their last names a...
medpagetoday.com
BUSM Opens New Clerkship Sites in California
Boston University School of Medicine has developed an affiliation with...
bumc.bu.edu
Researchers show value of tissue-engineering to repair major peripheral nerve injuries
Peripheral nerve injury (PNI) is a common consequence of traumatic...
medicalxpress.com
Ebola: timeline of a ruthless killer
Here are key dates in the current Ebola epidemic, the...
medicalxpress.com
Chile's Bachelet sends abortion bill to Congress
Chile's President Michelle Bachelet on Saturday pressed ahead with plans...
medicalxpress.com
Scientist considered father of birth control pill dies
Carl Djerassi, the chemist widely considered the father of the...
medicalxpress.com
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include tight control of...
medpagetoday.com
Mixed Results for Obamacare Tests in Primary-Care Innovation
(MedPage Today) -- Achieving the programs' goals turns out to...
medpagetoday.com
Grand Roundup: Top posts of January
The five most-read stories this month on Scope were: Eating...
scopeblog.stanford.edu
D.C Week: Administration Pushes Ahead on Multiple Fronts
(MedPage Today) -- More details on "precision medicine" and health...
medpagetoday.com
RA Mortality High but Improving (CME/CE)
(MedPage Today) -- Mortality rate gap between RA patients and...
medpagetoday.com
Rock, Paper, Lizards? That's Improbable!
(MedPage Today) -- The science of being drunk, and skepticism...
medpagetoday.com
Ebola reveals shortcomings of African solidarity
As Africa's leaders meet in Ethiopia to discuss the Ebola...
medicalxpress.com
Vyvanse OK'd for Binge Eating
(MedPage Today) -- FDA gives green light for new indication...
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +